Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5700001 | Clinical Oncology | 2007 | 5 Pages |
Abstract
Our results suggest that CD117 is not significantly overexpressed in HCC and there seems to be no role for the use of imatinib.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
G. Becker, A. Schmitt-Graeff, V. Ertelt, H.E. Blum, H.-P. Allgaier,